253 related articles for article (PubMed ID: 8397824)
1. Tay-Sachs disease screening and diagnosis: evolving technologies.
Hechtman P; Kaplan F
DNA Cell Biol; 1993 Oct; 12(8):651-65. PubMed ID: 8397824
[TBL] [Abstract][Full Text] [Related]
2. Tay-Sachs disease carrier screening: a model for prevention of genetic disease.
Kaplan F
Genet Test; 1998; 2(4):271-92. PubMed ID: 10464605
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis of hexosaminidase A deficiency and pseudodeficiency in the Berks County Pennsylvania Dutch.
Mules EH; Hayflick S; Dowling CE; Kelly TE; Akerman BR; Gravel RA; Thomas GH
Hum Mutat; 1992; 1(4):298-302. PubMed ID: 1301937
[TBL] [Abstract][Full Text] [Related]
4. A mutation common in non-Jewish Tay-Sachs disease: frequency and RNA studies.
Akerman BR; Zielenski J; Triggs-Raine BL; Prence EM; Natowicz MR; Lim-Steele JS; Kaback MM; Mules EH; Thomas GH; Clarke JT
Hum Mutat; 1992; 1(4):303-9. PubMed ID: 1301938
[TBL] [Abstract][Full Text] [Related]
5. Prenatal diagnosis of a Japanese family at risk for Tay-Sachs disease. Application of a fluorescent competitive allele-specific polymerase chain reaction (PCR) method.
Tamasu S; Nishio H; Ayaki H; Lee MJ; Mizutori M; Takeshima Y; Nakamura H; Matsuo M; Maruo T; Sumino K
Kobe J Med Sci; 1999 Dec; 45(6):259-70. PubMed ID: 10985159
[TBL] [Abstract][Full Text] [Related]
6. Tay-Sachs disease--carrier screening, prenatal diagnosis, and the molecular era. An international perspective, 1970 to 1993. The International TSD Data Collection Network.
Kaback M; Lim-Steele J; Dabholkar D; Brown D; Levy N; Zeiger K
JAMA; 1993 Nov; 270(19):2307-15. PubMed ID: 8230592
[TBL] [Abstract][Full Text] [Related]
7. Heterozygote screening for Tay-Sachs disease: past successes and future challenges.
Natowicz MR; Prence EM
Curr Opin Pediatr; 1996 Dec; 8(6):625-9. PubMed ID: 9018448
[TBL] [Abstract][Full Text] [Related]
8. Rapid nonradioactive tracer method for detecting carriers of the major Ashkenazi Jewish Tay-Sachs disease mutations.
Strasberg PM; Clarke JT
Clin Chem; 1992 Nov; 38(11):2249-55. PubMed ID: 1424119
[TBL] [Abstract][Full Text] [Related]
9. Prenatal Diagnosis of Tay-Sachs Disease.
Zhang J; Chen H; Kornreich R; Yu C
Methods Mol Biol; 2019; 1885():233-250. PubMed ID: 30506202
[TBL] [Abstract][Full Text] [Related]
10. Common HEXB polymorphisms reduce serum HexA and HexB enzymatic activities, potentially masking Tay-Sachs disease carrier identification.
Vallance H; Morris TJ; Coulter-Mackie M; Lim-Steele J; Kaback M
Mol Genet Metab; 2006 Feb; 87(2):122-7. PubMed ID: 16352452
[TBL] [Abstract][Full Text] [Related]
11. Origin and spread of the 1278insTATC mutation causing Tay-Sachs disease in Ashkenazi Jews: genetic drift as a robust and parsimonious hypothesis.
Frisch A; Colombo R; Michaelovsky E; Karpati M; Goldman B; Peleg L
Hum Genet; 2004 Mar; 114(4):366-76. PubMed ID: 14727180
[TBL] [Abstract][Full Text] [Related]
12. Mutational analyses of Tay-Sachs disease: studies on Tay-Sachs carriers of French Canadian background living in New England.
Triggs-Raine B; Richard M; Wasel N; Prence EM; Natowicz MR
Am J Hum Genet; 1995 Apr; 56(4):870-9. PubMed ID: 7717398
[TBL] [Abstract][Full Text] [Related]
13. Tay-Sachs disease-causing mutations and neutral polymorphisms in the Hex A gene.
Myerowitz R
Hum Mutat; 1997; 9(3):195-208. PubMed ID: 9090523
[TBL] [Abstract][Full Text] [Related]
14. Specificity and sensitivity of hexosaminidase assays and DNA analysis for the detection of Tay-Sachs disease gene carriers among Ashkenazic Jews.
Fernandes MJ; Kaplan F; Clow CL; Hechtman P; Scriver CR
Genet Epidemiol; 1992; 9(3):169-75. PubMed ID: 1387862
[TBL] [Abstract][Full Text] [Related]
15. Population-specific screening by mutation analysis for diseases frequent in Ashkenazi Jews.
DeMarchi JM; Caskey CT; Richards CS
Hum Mutat; 1996; 8(2):116-25. PubMed ID: 8844209
[TBL] [Abstract][Full Text] [Related]
16. Tay-Sachs disease as a model for screening inborn errors.
Blitzer MG; McDowell GA
Clin Lab Med; 1992 Sep; 12(3):463-80. PubMed ID: 1355703
[TBL] [Abstract][Full Text] [Related]
17. Biochemical and mutational analyses of HEXA in a cohort of Egyptian patients with infantile Tay-Sachs disease. Expansion of the mutation spectrum.
Ibrahim DMA; Ali OSM; Nasr H; Fateen E; AbdelAleem A
Orphanet J Rare Dis; 2023 Mar; 18(1):52. PubMed ID: 36907859
[TBL] [Abstract][Full Text] [Related]
18. An A-to-G mutation at the +3 position of intron 8 of the HEXA gene is associated with exon 8 skipping and Tay-Sachs disease.
Richard MM; Erenberg G; Triggs-Raine BL
Biochem Mol Med; 1995 Jun; 55(1):74-6. PubMed ID: 7551830
[TBL] [Abstract][Full Text] [Related]
19. Population-based carrier screening and prenatal diagnosis.
Strom CM
MLO Med Lab Obs; 2004 Aug; 36(8):12-7; quiz 20-1. PubMed ID: 15366363
[No Abstract] [Full Text] [Related]
20. Molecular analysis of the HEXA gene in Italian patients with infantile and late onset Tay-Sachs disease: detection of fourteen novel alleles.
Montalvo AL; Filocamo M; Vlahovicek K; Dardis A; Lualdi S; Corsolini F; Bembi B; Pittis MG
Hum Mutat; 2005 Sep; 26(3):282. PubMed ID: 16088929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
